Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-13

Clinical Trial Update: Survey of Human Rabies Immune Globulin Safety in Children

View source ↗

Summary

A pediatric safety study of Human Rabies Immune Globulin (HRIG) was terminated; no results are reported in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human Rabies Immune Globulin (rabies immune globulin (HRIG))

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Rabies, Rabies Human | Status: TERMINATED